Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
SERPINA5,Plasma serine protease inhibitor,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Wald ratio,1,0.86 [0.76-0.98],0.023742056430673,trans
SERPINA5,Plasma serine protease inhibitor,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.03 [0.99-1.07],0.197630523833777,trans
SERPINA5,Plasma serine protease inhibitor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,1.03 [0.98-1.09],0.223995137458307,trans
SERPINA5,Plasma serine protease inhibitor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,14,1.04 [0.96-1.12],0.353928266927599,trans
SERPINA5,Plasma serine protease inhibitor,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,0.98 [0.88-1.09],0.720884631741669,trans
SERPINA5,Plasma serine protease inhibitor,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,0.97 [0.83-1.13],0.720884631741669,trans
SERPINA5,Plasma serine protease inhibitor,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,1.01 [0.83-1.22],0.940189974347656,trans
